Haemoscope Corporation

Niles, IL 60714

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $963K
First Award Date 09/30/98
Most Recent Award Date 09/01/01

Key Personnel

Last Name Name Awards Contact
Cohen Eli Cohen 3

3 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/04
PI: Eli Cohen

Phase I results show that the modified Thrombelastograph(R) Coagulation Analyzer (TEG(R)) assay to monitor platelet glycoprotein Ilb/IIIa (GPIIb/IIla) receptor blockade in patients being treated with c7E3 Fab provides an equivalent or better assessment of platelet GPIIb/IIla receptor blockade than the "gold standard" turbidimetric platelet aggre...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 08/31/01
PI: Eli Cohen

Phase I results show that the modified Thrombelastograph(R) Coagulation Analyzer (TEG(R)) assay to monitor platelet glycoprotein Ilb/IIIa (GPIIb/IIla) receptor blockade in patients being treated with c7E3 Fab provides an equivalent or better assessment of platelet GPIIb/IIla receptor blockade than the "gold standard" turbidimetric platelet aggre...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/98 - 09/29/99
PI: Eli Cohen

The implementation of a modified Thrombelastograph Coagulation Analyzer (MTEG(TM)) with a new assay to monitor platelet glycoprotein Ilb/IIla (GPIIb/IIla) receptor blockade in patients being treated with the recently-approved antibody fragment c7E3 Fab is proposed. Based on preliminary results, we...